Exosome Diagnostics Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
98
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$15M
Exosome Diagnostics General Information
Description
Developer of biofluid-based diagnostics designed to deliver personalized precision healthcare that improves lives. The company's biofluid-based diagnostics harness the power of exosomes, important cell messengers carried within biofluids, such as serum, plasma, urine, cerebrospinal fluid and saliva, that contain RNA, DNA and proteins from their cell of origin, thereby enabling health care organizations or doctors non-invasive diagnosis of serious diseases, aiming to reduce or eliminate the need for tissue biopsies.
Contact Information
Website
www.exosomedx.comCorporate Office
- 266 Second Avenue
- Suite 200
- Waltham, MA 02451
- United States
Corporate Office
- 266 Second Avenue
- Suite 200
- Waltham, MA 02451
- United States
Exosome Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 15-Sep-2025 | $15M | Completed | Generating Revenue | ||
| 6. Merger/Acquisition | 01-Aug-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 05-Jul-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B2) | 07-Jan-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 12-Mar-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Feb-2012 | $1.29M | $20M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 11-May-2010 | $20M | $20M | Completed | Startup |
Exosome Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B2 | ||||||||
| Series B | 1,843,597 | $0.010000 | $1.07 | $14.24 | $14.24 | 1x | $14.24 | 14.92% |
| Series A | 629,162 | $0.010000 | $1.11 | $13.82 | $13.82 | 1x | $13.82 | 5.09% |
Exosome Diagnostics Comparisons
Industry
Financing
Details
Exosome Diagnostics Competitors (31)
One of Exosome Diagnostics’s 31 competitors is BioGenex Laboratories, a Corporation company based in Fremont, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioGenex Laboratories | Corporation | Fremont, CA | ||||
| Boreal Genomics | Formerly VC-backed | Vancouver, Canada | ||||
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA |
Exosome Diagnostics Patents
Exosome Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4584397-A1 | Methods of detecting sjögren's syndrome using salivary exosomes | Pending | 07-Sep-2022 | ||
| WO-2024054572-A1 | Methods of detecting sjögren's syndrome using salivary exosomes | Inactive | 07-Sep-2022 | ||
| WO-2023158869-A1 | Use of microvesicle signatures in the identification and treatment of renal disorders | Inactive | 18-Feb-2022 | ||
| EP-4370712-A1 | Methods of detecting sjögren's syndrome using salivary exosomes | Pending | 16-Jul-2021 | ||
| WO-2023288130-A1 | Methods of detecting sjögren's syndrome using salivary exosomes | Inactive | 16-Jul-2021 | C12Q1/6832 |
Exosome Diagnostics Signals
Exosome Diagnostics Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arcus Ventures | Venture Capital | Minority | ||
| Bio-Techne | Corporation | Majority | ||
| Blue Ridge Capital | Real Estate | Minority | ||
| CD-Venture | Venture Capital | Minority | ||
| Forbion | Venture Capital | Minority |
Exosome Diagnostics FAQs
-
When was Exosome Diagnostics founded?
Exosome Diagnostics was founded in 2008.
-
Where is Exosome Diagnostics headquartered?
Exosome Diagnostics is headquartered in Waltham, MA.
-
What is the size of Exosome Diagnostics?
Exosome Diagnostics has 98 total employees.
-
What industry is Exosome Diagnostics in?
Exosome Diagnostics’s primary industry is Laboratory Services (Healthcare).
-
Is Exosome Diagnostics a private or public company?
Exosome Diagnostics is a Private company.
-
What is the current valuation of Exosome Diagnostics?
The current valuation of Exosome Diagnostics is .
-
What is Exosome Diagnostics’s current revenue?
The current revenue for Exosome Diagnostics is .
-
How much funding has Exosome Diagnostics raised over time?
Exosome Diagnostics has raised $137M.
-
Who are Exosome Diagnostics’s investors?
Arcus Ventures, Bio-Techne, Blue Ridge Capital, CD-Venture, and Forbion are 5 of 11 investors who have invested in Exosome Diagnostics.
-
Who are Exosome Diagnostics’s competitors?
BioGenex Laboratories, Boreal Genomics, CirculoGene, Foundation Medicine, and Decipher Urologic Cancers are some of the 31 competitors of Exosome Diagnostics.
-
When was Exosome Diagnostics acquired?
Exosome Diagnostics was acquired on 15-Sep-2025.
-
Who acquired Exosome Diagnostics?
Exosome Diagnostics was acquired by MDxHealth.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process